Abstract
These authors conducted a cross-sectional and population-based study to examine rates of residual neuropathy and overall health consequences among 40 patients with prior Guillain-Barre Syndrome (GBS) and among age-, sex-, weight-, and height-matched controls. Evaluations were performed 1 to 13 years after GBS onset and included questionnaires, clinical examination, objective measures (quantitative sensory testing, …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
